Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk | Zendy

Beate Pesch | Zendy; Yon Ko | Zendy; Hiltrud Brauch | Zendy; Ute Hamann | Zendy; Volker Harth | Zendy; Sylvia Rabstein | Zendy; Christiane Barbara Pierl | Zendy; HansPeter Fischer | Zendy; Christian Baisch | Zendy; Christina Justenhoven | Zendy; Ulrich Ranft | Zendy; Thomas Brüning | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Factors Modifying the Association Between Hormone-Replacement Therapy and Breast Cancer Risk

Author(s) -

Beate Pesch,

Yon Ko,

Hiltrud Brauch,

Ute Hamann,

Volker Harth,

Sylvia Rabstein,

Christiane Barbara Pierl,

HansPeter Fischer,

Christian Baisch,

Christina Justenhoven,

Ulrich Ranft,

Thomas Brüning

Publication year - 2005

Publication title -

european journal of epidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.825

H-Index - 111

eISSN - 1573-7284

pISSN - 0393-2990

DOI - 10.1007/s10654-005-0032-0

Subject(s) - medicine , breast cancer , hormone replacement therapy (female to male) , odds ratio , menopause , gynecology , risk factor , obstetrics , family history , risk factors for breast cancer , hormone therapy , population , epidemiology , confidence interval , cancer , environmental health , testosterone (patch)

Hormone-replacement therapy (HRT) is an established risk factor for breast cancer. HRT users are different from non-users with respect to socio-economic and other characteristics. There may be women where the HRT-related risk could be modulated by other factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research